Glenmark Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Harish Kuber has resigned from his position as Company Secretary & Compliance Officer at Glenmark Pharmaceuticals, effective May 29, 2026, citing early retirement after more than 9.5 years with the company. He has offered to continue employment for a few months to ensure a smooth transition. Ms. Rashmi Khandelwal has been appointed as the new Company Secretary (Key Managerial Personnel) effective May 30, 2026. She brings over 17 years of experience in corporate governance, regulatory matters, and legal functions across listed entities and financial institutions. Mr. Samir Kazi continues as Executive Vice President and Head – Legal, Compliance & Intellectual Property.
The resignation appears to be amicable and driven by personal decision rather than any dispute or governance concern. The immediate appointment of a well-qualified replacement with strong governance credentials should provide continuity in compliance and secretarial functions for shareholders.